The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

February 5, 2025

Study Completion Date

June 2, 2025

Conditions

Nodular Basal Cell Carcinoma

Interventions

DRUG

D-MNA 200 mcg

D-MNA , (doxorubicin) patch, 200 mcg

DRUG

D-MNA 100 mcg

D-MNA (doxorubicin) patch, 100 mcg

OTHER

Placebo

P-MNA patch, placebo

Trial Locations (6)

RECRUITING

Site#2, Knoxville

RECRUITING

Site #1, Rolling Meadows

RECRUITING

Site #5, Mandeville

NOT_YET_RECRUITING

Site #6, San Diego

RECRUITING

Site #4, Fresno

RECRUITING

Site #3, Highlands

All Listed Sponsors

lead

SkinJect, Inc.

INDUSTRY